A pair of 'significant' findings from an otherwise inconclusive U.S. intelligence report on coronavirus origins
A review by the United States' intelligence community did not reach a firm conclusion on the origin of the coronavirus that sparked the COVID-19 pandemic, but it still may prove quite helpful moving forward.
While the report, ordered by President Biden earlier this year, determined only that both natural spillover from an infected animal and a lab leak were plausible theories as to how the pathogen jumped to humans, an unclassified summary of the report released Friday did show that there was broad agreement among the intelligence community on multiple areas, including that the virus was "not developed as a biological weapon" and that Chinese officials "did not have foreknowledge" of the virus ahead of the initial outbreak of COVID-19 in Wuhan, China, back in the fall of 2019.
Those don't provide a clear answer to the origin question, but they're still "significant," Robert Garry, a microbiologist at Tulane University School of Medicine, told NPR. He argued that if government officials didn't know about the coronavirus, then it's unlikely the Wuhan Institute of Virology — the lab most often associated with a potential lab leak — would have, either. "It's huge to mainly rule out that this is a product of engineering," Garry told Nature.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Per NPR, Garry thinks the report moves "the needle" toward "the natural origin" theory in that case. "I think you have to look at the scientific data that's out there," he said. "Follow the science, follow the animals." Read more at NPR and Nature.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
‘The worry is far from fanciful’Instant Opinion Opinion, comment and editorials of the day
-
How are Americans bracing for the end of SNAP?TODAY'S BIG QUESTION Millions depend on supplemental federal food funds that are set to expire this month, as the government shutdown begins to be acutely felt
-
Book review: ‘Joyride: A Memoir’Feature A journalist’s story of how she chased and accomplished her dreams
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
